Loading company…
Vysioneer develops AI tools for brain tumor contouring and oncology treatment insights.
Vysioneer developed VBrain, an FDA-cleared AI tool that contours brain metastases, meningiomas, and acoustic neuromas. Its technology supports tumor measurement and provides lesion-level insights into drug efficacy. Founded in 2019 and based in Cambridge, US, it raised USD 1.7 million in Seed funding in February 2024, led by Chaac Ventures.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in